Journal article
A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211.
Authors
Morris D; Tu D; Tehfe MA; Nicholas GA; Goffin JR; Gregg RW; Shepherd FA; Murray N; Wierzbicki R; Lee CW
Journal
Journal of Clinical Oncology, Vol. 34, No. 15_suppl, pp. e20512–e20512
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.e20512
ISSN
0732-183X